-
Central Control of Opioid Mechanical Hypersensitivity
2026-09-04
Yin et al. identify a brain-to-spinal opioid pathway linking lateral parabrachial MOR neurons, hypothalamic dynorphin neurons, and spinal KOR-positive GABAergic neurons to morphine-induced mechanical hypersensitivity and analgesic tolerance. The findings separate central control of mechanical pain from better-established thermal mechanisms and suggest that circuit-specific interventions may restore morphine responsiveness in mice.
-
SD 169 (indole-5-carboxamide) Assay Guide
2026-09-03
This scenario-based guide explains how SD 169 (indole-5-carboxamide), SKU C5850, can support controlled p38α/β pathway experiments in viability, apoptosis, type 1 diabetes, and axonal regeneration research. It connects formulation data with practical controls for interpretation, solvent handling, storage, and vendor selection.
-
BKT140: A CXCR4 Antagonist for Cancer Research
2026-09-03
Explore how BKT140 (BL-8040) converts CXCR4 biology into actionable oncology and stem-cell assays. This guide emphasizes assay selection, mechanistic interpretation, formulation, and translational decision-making beyond conventional theranostic reviews.
-
Stattic: STAT3 Inhibition Workflow for HNSCC
2026-09-02
Stattic enables mechanism-focused interrogation of STAT3 dimerization, nuclear translocation, survival signaling, and treatment response in cancer models. This guide translates its reported HNSCC activity into practical dose-response, pathway-validation, apoptosis, radiosensitization, and lymphatic endothelial workflows while emphasizing controls and troubleshooting.
-
Degarelix acetate: Practical GnRH Assay Workflows
2026-09-02
Build reproducible GnRH receptor, pituitary hormone, and prostate cancer research assays with concentration and handling strategies tailored to Degarelix acetate. A reference-backed isotope-labeling workflow also shows how to separate pharmacology experiments from LC–MS exposure analysis.
-
TH287 MTH1 Inhibitor for CRPC Radiosensitization
2026-09-01
TH287 converts oxidized nucleotide stress into a controllable vulnerability, helping researchers examine cancer cell selective cytotoxicity and radiation response. A CRPC study highlights treatment sequence as a major experimental variable, with the strongest combination effect when irradiation followed TH287 exposure by 12 hours.
-
Protease Inhibitor Cocktail for MS Workflows
2026-09-01
Protect extracted proteins with a broad-spectrum, AEBSF-free formulation designed for proteomics and biochemical workflows. This guide shows how to use the 50X DMSO stock, preserve cleavage-sensitive biology, and troubleshoot extraction, DMSO, metalloprotease, and mass spectrometry issues.
-
Olive Biophenols and Aβ42 Pathology in AD Models
2026-08-31
Omar and colleagues examined whether olive biophenols could inhibit Aβ42 aggregation under peptide-only, copper-associated, and L-DOPA-associated conditions, then tested an oleuropein-containing olive leaf extract in an APPswe/PS1dE9 mouse model. The study connects direct anti-amyloid activity with reduced SH-SY5Y toxicity and lower cortical and hippocampal plaque deposition, while also identifying bioavailability and blood–brain barrier penetration as unresolved translational questions.
-
Cardiogreen for Vascular Imaging and PDT
2026-08-31
Cardiogreen combines vascular-space fluorescence with a practical near-infrared light-activation workflow for diagnostics, cell assays, and exploratory tumor studies. This guide connects cardiac, hepatic, ophthalmic, and photodynamic applications with the calreticulin-centered immunology reported in oral squamous cell carcinoma research.
-
12-O-tetradecanoyl phorbol-13-acetate for ERK Assays
2026-08-30
Use 12-O-tetradecanoyl phorbol-13-acetate (TPA) as a controlled protein kinase C and ERK/MAPK stimulus for rapid signaling assays, kinase measurements, and approved skin cancer model workflows. Its greatest value is temporal: a carefully designed dose-and-time matrix can separate acute pathway activation from downstream effects on proliferation, differentiation, or immune-cell behavior.
-
Tunicamycin: From ER Stress to Translational Insight
2026-08-29
Tunicamycin is more than a standard ER stress reagent: as an N-glycosylation inhibitor, it provides a controlled way to connect glycoprotein processing with macrophage inflammation and emerging hepatic fibrosis mechanisms involving QRICH1 and HMGB1.
-
Bestatin Hydrochloride: Applied Research Workflows
2026-08-28
Bestatin hydrochloride, also known as Ubenimex, supports mechanism-driven studies of aminopeptidase activity across endothelial, tumor, and neuronal models. This guide translates its dual aminopeptidase profile into practical angiogenesis inhibition, tumor growth and invasion research, and neuropeptide-processing workflows with controls that help distinguish target engagement from nonspecific toxicity.
-
Influenza Hemagglutinin (HA) Peptide Workflow
2026-08-28
Use this HA tag peptide to recover tagged proteins under controlled, antibody-compatible conditions rather than relying only on harsh elution. The workflow translates a cancer chemoproteomics example into practical immunoprecipitation, interaction-mapping, and protein-purification decisions.
-
TCF25 Links Glucose Starvation to Lysosomal Cell Death
2026-08-27
Ren et al. identify TCF25 as a nutrient-responsive regulator that increases V-ATPase-dependent lysosomal acidification during glucose starvation. Their data show that this pathway is initially adaptive, supporting autophagy and ATP production, but prolonged activation drives ferritinophagy, lysosomal membrane permeability, and lysosome-dependent cell death, while TCF25 deficiency protects mice from hepatic ischemia-reperfusion injury.
-
LMW Fucoidan Targets Ferroptosis in Pulmonary Fibrosis
2026-08-27
The reference study links low molecular weight fucoidan from Laminaria japonica to suppression of ferroptosis-associated injury in a bleomycin-induced pulmonary fibrosis model. By combining pathology, redox and iron-related measurements, mitochondrial assessment, and LC–MS metabolomics, the work provides a mechanistic framework for evaluating how fucoidan may protect alveolar tissue.